| 1 |
Kahaly GJ, Bartalena L, Hegedüs L, et al. 2018 Eur-opean Thyroid Association guideline for the management of Graves' hyperthyroidism[J]. Eur Thyroid J, 2018, 7 (4): 167-186.
|
| 2 |
Ross DS, Burch HB, Cooper DS, et al. 2016 Americ-an Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis[J]. Thyroid, 2016, 26 (10): 1343-1421.
|
| 3 |
王永艳，阎胜利，贾兆通，等. 甲状腺功能亢进症并发肝损害病人的临床分析[J]. 青岛大学医学院学报，2012，48(1):23-26.
|
| 4 |
朱萍，卫红艳，王坤玲，等. Graves病甲状腺功能亢进症性肝损害的相关因素分析[J]. 国际内分泌代谢杂志，2017，37(3):164-167.
|
| 5 |
黄卫东，姚美芬. 甲亢危象的诊治[J/CD]. 中华危重症医学杂志（电子版），2010，3(1):1-5.
|
| 6 |
李文华，袁刚，赵西平. 甲状腺功能亢进症与肝损害[J]. 内科急危重症杂志，2010，16(1):8-12.
|
| 7 |
Biscoveanu M, Hasinski S. Abnormal results of liver function tests in patients with Graves' disease[J]. Endocr Pract, 2000, 6 (5): 367-369.
|
| 8 |
Papachristos DA, Huynh J, Grossman M, et al. Liver dysfunction and anti-thyroid therapy[J]. SAGE Open Med Case Rep, 2015 (3): 2050313X14568335.
|
| 9 |
Heidari R, Niknahad H, Jamshidzadeh A, et al. Fact-ors affecting drug-induced liver injury: antithyroid drugs as instances[J]. Clin Mol Hepatol, 2014, 20 (3): 237-248.
|
| 10 |
尹士男. 甲亢合并肝损害的临床合理用药[J]. 药品评价，2016，13(1):14-17,20.
|
| 11 |
中华医学会感染病学分会肝衰竭与人工肝学组，中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南（2018年版）[J]. 现代医药卫生，2018，34(24):3897-3904.
|
| 12 |
Shen C, Zhao CY, Liu F, et al. Acute-on-chronic liver failure due to thiamazole in a patient with hyperthyroidism and trilogy of Fallot: case report[J]. BMC Gastroenterol, 2010 (10): 93.
|
| 13 |
Wang MT, Lee WJ, Huang TY, et al. Antithyroid drug-related hepatotoxicity in hyperthyroidism patients: a population-based cohort study[J]. Br J Clin Pharmacol, 2014, 78 (3): 619-629.
|
| 14 |
Miyamura T, Kanda T, Minemura S, et al. Acute liver failure associated with propylthiouracil in a pregnant 26-year-old woman[J]. Case Rep Gastroenterol, 2013, 7 (2): 240-244.
|
| 15 |
Malik R, Hodgson H. The relationship between the thyroid gland and the liver[J]. QJM, 2002, 95 (9): 559-569.
|
| 16 |
陈永虎，杨琴琴，陈俏春. 中药导致肝损害52例临床特征分析[J/CD]. 中华危重症医学杂志（电子版），2017，10(5):341-342.
|
| 17 |
Majeed M, Babu A. Cholestasis secondary to hyperthy-roidism made worse by methimazole[J]. Am J Med Sci, 2006, 332 (1): 51-53.
|
| 18 |
Arab DM, Malatjalian DA, Rittmaster RS. Severe cho-lestatic jaundice in uncomplicated hyperthyroidism treated with methimazole[J]. J Clin Endocrinol Metab, 1995, 80 (4): 1083-1085.
|
| 19 |
Mikhail NE. Methimazole-induced cholestatic jaundice[J]. South Med J, 2004, 97 (2): 178-182.
|
| 20 |
Ding Y, Xing J, Fang Y, et al. 131I therapy for 345 patients with refractory severe hyperthyroidism: without antithyroid drug pretreatment[J]. Exp Biol Med (Maywood), 2016, 241 (3): 290-295.
|
| 21 |
张庆，张伦理，向天新，等. 人工肝系统联合131I治疗甲状腺功能亢进症合并肝衰竭研究[J]. 中华肝脏病杂志，2016，24(10):778-782.
|